Prevention of venous thromboembolism with low molecular-weight heparin in patients with multiple myeloma treated with thalidomide and chemotherapy

MeSH terms

• Adolescent
• Adult
• Aged
• Anticoagulants / therapeutic use*
• Antineoplastic Combined Chemotherapy Protocols / adverse effects*
• Dexamethasone / administration & dosage
• Doxorubicin / administration & dosage
• Female
• Heparin, Low-Molecular-Weight / therapeutic use*
• Humans
• Male
• Middle Aged
• Multiple Myeloma / complications*
• Multiple Myeloma / diagnosis
• Multiple Myeloma / drug therapy
• Thalidomide / administration & dosage
• Thromboembolism / etiology
• Thromboembolism / prevention & control*
• Treatment Outcome
• Venous Thrombosis / etiology
• Venous Thrombosis / prevention & control*
• Vincristine / administration & dosage